Meeting
2020 Genitourinary Cancers Symposium
Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC).
Authors
Santosh Gupta
Duke Cancer Institute, Duke University, Durham, NC
Santosh Gupta , Susan Halabi , Gabor Kemeny , Monika Anand , David M. Nanus , Paraskevi Giannakakou , Daniel J. George , Simon Gregory , Andrew J. Armstrong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research
Clinical Trial Registration Number
NCT02269982
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 147)
Abstract #
147
Poster Bd #
G5
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.
First Author: Jing Li
Poster
2018 ASCO Annual Meeting
Analysis of genomic alterations in matched circulating tumor cell DNA (CTC DNA) and plasma tumor DNA (ctDNA) in men with metastatic castration resistant prostate cancer (mCRPC).
First Author: Santosh Gupta
Poster
2017 Genitourinary Cancers Symposium
Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.
First Author: Adam G. Sowalsky
Poster
2014 Genitourinary Cancers Symposium
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.
First Author: Andrew J. Armstrong